Form 4: Neuronetics EVP Sells Shares for Tax Obligations

Neuronetics' Executive Vice President and Chief Legal Officer, William Andrew Macan, sold 609 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• William Andrew Macan, EVP, CLO and CS of Neuronetics, Inc. (STIM), reported a sale of 609 shares of common stock.
• The transaction occurred on March 4, 2026, at a weighted average price of $1.34 per share.
• The shares were sold in multiple transactions with prices ranging from $1.28 to $1.39.
• The sale was non-discretionary and executed to satisfy tax withholding obligations upon the vesting of a restricted stock unit award.
• Following this transaction, Mr. Macan beneficially owns 879,525 shares of Neuronetics common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine administrative transaction related to executive compensation rather than a reflection of company performance or management's outlook.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that non-discretionary sales by executives to cover tax obligations upon the vesting of restricted stock units are a common and routine occurrence in public companies. This type of transaction is typically not indicative of management's sentiment towards the company's future prospects but rather a standard part of executive compensation and tax planning.

Comparison to Industry Standards

• This transaction is a standard practice for executives receiving equity compensation.
• It aligns with common industry practices where executives sell a portion of vested equity to cover statutory tax liabilities, similar to how executives at companies like Medtronic (MDT) or Boston Scientific (BSX) manage their RSU vestings.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary sale for tax purposes and does not signal a change in management's confidence or company fundamentals.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of a relatively small number of shares by an executive to cover tax obligations associated with restricted stock unit vesting. Such transactions are common and do not typically reflect a change in the company's fundamentals or the executive's long-term view. Therefore, it provides no new information that would warrant a change from a 'hold' recommendation.

Keywords

Neuronetics, STIM, Form 4, Insider Sale, Executive Compensation, Restricted Stock Units, Tax Withholding, William Andrew Macan, Corporate Officer